chr1-215965369-A-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM5BP4_StrongBS2_Supporting
The NM_206933.4(USH2A):āc.7068T>Gā(p.Asn2356Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000312 in 1,613,936 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N2356S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.7068T>G | p.Asn2356Lys | missense_variant | Exon 37 of 72 | 1 | NM_206933.4 | ENSP00000305941.3 | ||
USH2A | ENST00000674083.1 | c.7068T>G | p.Asn2356Lys | missense_variant | Exon 37 of 73 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000784 AC: 197AN: 251316Hom.: 0 AF XY: 0.000736 AC XY: 100AN XY: 135814
GnomAD4 exome AF: 0.000310 AC: 453AN: 1461618Hom.: 4 Cov.: 31 AF XY: 0.000323 AC XY: 235AN XY: 727108
GnomAD4 genome AF: 0.000335 AC: 51AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.000349 AC XY: 26AN XY: 74496
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30073356, 30245029, 23591405, 25356976, 24938718, 25078356, 24853665, 26346818, 29625443, 30804660, 32090030, 33105608, 34426522, 33691693, 33090715, 35114279, 35860547, 32188678, 32675063, 35836572, 30826590, 36597107, 34515852, 36504663, 33124170, 23967202) -
- -
USH2A: BP4, BS1, BS2 -
Usher syndrome type 2A Uncertain:2Benign:1
- -
- -
- -
not specified Uncertain:1Benign:1
- -
Variant summary: USH2A c.7068T>G (p.Asn2356Lys) results in a non-conservative amino acid change located in the Fibronectin type III domain (IPR003961) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.001 in 291028 control chromosomes, predominantly at a frequency of 0.01 within the East Asian subpopulation in the gnomAD database and has also been reported as a common variant in the Japanese normal hearing population (example, Moteki_2016). This frequency is close to or almost similar (i.e., not significantly lower) than estimated for a pathogenic variant in USH2A causing Usher Syndrome (0.01 in East Asian cohorts vs 0.011), supporting a benign outcome. In a cross sectional ascertainment spanning 2013-2021, c.7068T>G has been reported in the literature as a VUS and/or non-informative genotype in settings of multigene panel testing predominantly among East Asian cohorts of individuals with a variety of Usher syndrome related manifestations such as hearing loss (example, Miyagawa_2013), sporadic retinal dystrophy (example, Glockle_2014), Inherited Retinal Degeneration cohort (example, Huang_2015), Japanese Normal Hearing cohort (Moteki_2016), Usher syndrome cohort (example, Galli-Resta_2018, Meng_2021), an individual with Usher syndrome compound heterozygous for causative variants in the MYO7A gene (example, Li_2019), possible digenic association proposed in an individual with Inherited Retinal Degeneration (example, Liu_2020). These report(s) do not provide unequivocal conclusions about association of the variant with Usher Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments (benign/likely benign, n=3; VUS, n=4). Some submitters cite overlapping evidence utilized in the context of this evaluation. Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at